1Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology,2002,62(2): 157-166.
2Akagi K, Ikeda Y, Sumiyoshi Y, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery,2002,131(1 Suppl): S109-113.
3Takahashi M, Yoshimoto T, Kubo H. Molecular mechanisms of lymphangiogenesis. Int J Hematol, 2004,80(1): 29-34.
4Tille JC, Nisato R, Pepper MS. Lymphangiogenesis and tumour metastasis. Novartis Found Symp, 2004, 256 : 112-131; discussion132-136,259-269.
5Hanrahan V, Currie MJ, Gunningham SP, et al. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGFB, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol,2003,200(2) : 183-194.
6Van Trappen PO, Steele D, Lowe DG, et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol,2003,201(4): 544-554.
7Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melano ma. Cancer Res,2002,62(23): 7059-7065.
8Kazama S, Kitayama J, Watanabe T, et al. Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa. Hepatogastroenterology, 2004, 51(56): 391-395.
9Shimizu K, Kubo H, Yamaguchi K, et al. Suppression of VEG FR-3 signaling inhibits lymph node metastasis in gastric cancer.Cancer Sci,2004,95(4): 328-333.
10Hashimoto I, Kodama J, Seki N, et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer,2001,85(1):93-97.
5Schneider M,Othman-Hassan K,Christ B,et al.Lymphangioblasts in the avian wing bud[J].Dev Dyn,1999,216(4):311-319.
6He Y,Karpanen T,Alitalo K.Role of lymphangiogenic factors in tumor metastasis[J].Biochim Biophys Acta,2004,1654(1):3-12.
7Sakuragi N,Takeda N,Hareyama H,et al.A multivariate analysis of blood vessel and lymph vessel invasion as predictor of ovarian and lymph node metastases in patient with cervical carcinoma[J].Cancer,2000,88(1):2578-2583.
8Joukov V,Pajusola K,Kaipainen A,et al.A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4(VEGFR-3)and KDR(VEGFR-2)receptor tyrosine kinases[J].EMBOJ,1996,15:290.
9Pepper MS,Tille JC,Nisato R,et al.Lymphangiogenesis and tumor metastasis[J].Cell Tissue Res,2003,314(1):167-177.
10Su JL,Yen CJ,Chen PS,et al.The role of the VEGF-C/VEGFR-3 axis in cancer progression[J].Br J Cancer,2007,96(4):541-545.
